These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 4703818)

  • 1. A role of the dietary lipid in the ability of phenobarbital to stimulate drug detoxification.
    Century B
    J Pharmacol Exp Ther; 1973 May; 185(2):185-94. PubMed ID: 4703818
    [No Abstract]   [Full Text] [Related]  

  • 2. Time course differences in the metabolism of drugs by hepatic microsomes from rats, rabbits and mice.
    Gram TE; Fouts JR
    J Pharmacol Exp Ther; 1966 Jun; 152(3):363-71. PubMed ID: 5922307
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of thiamine consumption on liver microsomal drug-metabolizing pathways.
    Grosse W; Wade AE
    J Pharmacol Exp Ther; 1971 Mar; 176(3):758-65. PubMed ID: 4398746
    [No Abstract]   [Full Text] [Related]  

  • 4. Cadmium inhibition of hepatic drug metabolism in the rat.
    Hadley WM; Miya TS; Bousquet WF
    Toxicol Appl Pharmacol; 1974 May; 28(2):284-91. PubMed ID: 4850841
    [No Abstract]   [Full Text] [Related]  

  • 5. Inductive effects of 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane(DDT), phenobarbital, and benzpyrene on microsomal cytochrome B450, ethyl isocyanide spectra, and metabolism in vivo of zoxazolamine and hexobarbital in the mouse.
    Abernathy CO; Philpot RM; Guthrie FE; Hodgson E
    Biochem Pharmacol; 1971 Sep; 20(9):2395-400. PubMed ID: 5163150
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction between manganese and phenobarbital on hexobarbital hypnosis in the male rat.
    Deimling MJ; Schnell RC
    Res Commun Chem Pathol Pharmacol; 1983 Jul; 41(1):165-8. PubMed ID: 6622829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dibromotetrafluoroethane inhalation on hepatic drug metabolism in mice.
    Murphy JP; Van Stee EW; Back KC
    Biochem Pharmacol; 1973 Nov; 22(22):2843-51. PubMed ID: 4761555
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hyaluronidase and sleep].
    Safta L; Cuparencu B; Mierut G; Zillmann J
    Anesth Analg (Paris); 1972; 29(1):52-7. PubMed ID: 5069152
    [No Abstract]   [Full Text] [Related]  

  • 9. 5,5'-Diphenyl-2-thiohydantoin (DPTH): an inducer of microsomal drug-metabolizing enzymes.
    Dalton C; Kamm JJ; Bartl P
    J Pharmacol Exp Ther; 1972 Sep; 182(3):491-9. PubMed ID: 5055407
    [No Abstract]   [Full Text] [Related]  

  • 10. [Metabolic drug-drug interactions of chlorphenethiazine and chlorpromazine].
    Borchert HH; Pfeifer S; Bina B
    Pharmazie; 1984 Jan; 39(1):46-8. PubMed ID: 6718468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal pattern and reversal of impaired hepatic mono-oxygenases by phenobarbital in rats with developing and established adjuvant disease.
    Mathur PP; Smyth RD; Witmer CM; Carr GS; Reavey-Cantwell NH
    J Pharmacol Exp Ther; 1977 Oct; 203(1):169-83. PubMed ID: 909051
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies in mice on the effectiveness of various methods of enzyme induction with phenobarbital].
    Buzello W; Scholler KL; Schöppe B
    Arzneimittelforschung; 1973 Sep; 23(9):1337-9. PubMed ID: 4801232
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction of gluconeogenesis and mixed function oxidation.
    Thurman G; Scholz R
    Hoppe Seylers Z Physiol Chem; 1970 Mar; 351(3):294-5. PubMed ID: 4392988
    [No Abstract]   [Full Text] [Related]  

  • 14. Stereoselective metabolism of the enantiomers of hexobarbital.
    Furner RL; McCarthy JS; Stitzel RE; Anders MW
    J Pharmacol Exp Ther; 1969 Oct; 169(2):153-8. PubMed ID: 5824599
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of phenobarbital on the metabolism and analgesic effect of methadone in rats.
    Alvares AP; Kappas A
    J Lab Clin Med; 1972 Mar; 79(3):439-51. PubMed ID: 5061397
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of iron, riboflavin and iodide deficiencies on hepatic drug-metabolizing enzyme systems.
    Catz CS; Juchau MR; Yaffe SJ
    J Pharmacol Exp Ther; 1970 Aug; 174(2):197-205. PubMed ID: 5451357
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic expression of aryl hydrocarbon hydroxylase induction. Presence or absence of association with zoxazolamine, diphenylhydantoin, and hexobarbital metabolism.
    Robinson JR; Nebert DW
    Mol Pharmacol; 1974 May; 10(3):484-93. PubMed ID: 4852151
    [No Abstract]   [Full Text] [Related]  

  • 18. The diphasic action of halothane on the oxidative metabolism of drugs by the liver. An in-vitro study in the rat.
    Brown BR
    Anesthesiology; 1971 Sep; 35(3):241-6. PubMed ID: 5095536
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the mechanism of inhibition of drug biotransformation by cyclic adenine nucleotides.
    Weiner M; Buterbaugh GG; Blake DA
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):37-50. PubMed ID: 4153090
    [No Abstract]   [Full Text] [Related]  

  • 20. Differences in the oxidative metabolism of drugs by liver microsomes.
    Kato R; Takayanagi M; Oshima T
    Jpn J Pharmacol; 1969 Mar; 19(1):53-62. PubMed ID: 5306221
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.